Vanguard Portfolio Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.44B Buy
120,474,634
+1,239,604
+1% +$33M 0.16% 107
2026
Q2
$2.87B Buy
119,235,030
+2,500,335
+2% +$65.4M 0.13% 143
2026
Q1
$3.28B Buy
+116,734,695
New +$3.11B 0.17% 101

Other funds holding PFE

Vanguard Portfolio Management's PFE Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Pfizer (PFE) stake by 1% in Q3 2026, buying an estimated $33M and bringing the position to 120,474,634 shares worth $3.44B. The position accounts for 0.16% of the portfolio, ranked #107.

Vanguard Portfolio Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Vanguard Portfolio Management held 120,474,634 shares of Pfizer worth $3.44B as of Q3 2026.
  • Vanguard Portfolio Management bought 1,239,604 Pfizer shares in Q3 2026, an estimated $33M.
  • Pfizer made up 0.16% of Vanguard Portfolio Management's portfolio in Q3 2026, its #107 holding.
  • Vanguard Portfolio Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.